Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: Development of a biomarker strategy for gastric atrophy in high-risk groups

British Journal of Cancer

Volumn 73, Issue 6, 1996, Pages 819-824

  Knight, T ^a   Wyatt, J ^b   Wilson, A ^a   Greaves, S ^a   Newell, D ^c   Hengels, K ^d   Corlett, M ^a   Webb, P ^e   Forman, D ^e,f   Elder, J ^a  

^a School of Postgraduate Medicine   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Gastric atrophy; Helicobacter pylori; Pepsinogen

Indexed keywords

BIOLOGICAL MARKER; PEPSINOGEN;

ACHLORHYDRIA; ADULT; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; CHRONIC GASTRITIS; DIGESTIVE TRACT ENDOSCOPY; ENZYME BLOOD LEVEL; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; HYPERGASTRINEMIA; MALE; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; STOMACH BIOPSY; STOMACH CARCINOMA;

EID: 9244223552     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.144     Document Type: Article

References (34)

1. ARDILL J. (1979). Radioimmunoassay of G.I. hormones. Clin. Endocrinol. Metab., 8, 265-280.
2. BRANDT-RAUF PW. (1987). Occupational cancer and carcinogenesis. Occupational Medicine, 2, 123-133.
3. COGGON D, BARKER DJP AND COLE RB. (1990). Stomach cancer and work in dusty industries. Br. J. Ind. Med., 47, 298-301.
4. CORREA P. (1988). A human model of gastric carcinogenesis. Cancer Res., 48, 3554-3560.
5. DIXON MF. (1992). Helicobacter pylori and chronic gastritis. In Helicobacter pylori and gastroduodenal disease. 2nd edn. Rathborne BJ, Heatley RV. (eds). pp. 124-139. Blackwell Scientific: Oxford.
6. DIXON MF. (1994). Recent advances in gastritis. Curr. Diagn. Pathol., 1, 80-89.
7. DIXON MF, WYATT JI, BURKE DA AND RATHBONE BJ. (1988). Lymphocytic gastritis - relationship with Campylobacter pylori infection. J. Pathol., 154, 125-132.
8. GRAHAM S AND LILIENFIELD AM. (1958). Genetic studies of gastric cancer in humans. Cancer, 11, 945-958.
9. GRIFFITHS AP, WYATT JI, JACK AS AND DIXON MF. (1994). Lymphocytic gastritis, gastric adenocarcinoma and primary gastric lymphoma. J. Clin. Pathol., 47, 1123-1124.
10. HEILMANN KL AND BORCHARD F. (1991). Gastritis due to spiral-shaped bacteria other than Helicobacter pylori, clinical, histological and ultrastructural findings. Gut, 32, 137-140.
11. HENGELS KJ AND STROHMEYER G. (1989). Pepsinogens A and C: purification from human gastric mucosa and determination in serum by optimised radioimmunoassays. Zeitung Gastroenterologic, 27, 406-411.
12. JASS JR. (1980). Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J. Clin. Pathol., 33, 801-810.
13. KEKKI M, SAMLOFF IM, VARIS K AND IHAMAKI T. (1991). Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand. J. Gastroenterol., 26, 109-116.
14. KNIGHT T, GREAVES S, WILSON A, HENGELS K, NEWELL D, CORLETT M, WEBB P, FORMAN D AND ELDER J. (1995). Variability in serum pepsinogen levels in an asymptomatic population. Eur. J. Gastroenterol. Hepatol. 7, in press.
15. LANGMAN MJS. (1988). Genetic influences upon gastric cancer frequency. In Gastric Carcinogenesis, Reed PI and Hill MJ (eds). pp. 81 -86. Excerpta Medica: Oxford.
16. LEE S, IIDA M, YAO T, SHINDS S, NOSE Y, AKAZAWA K, OKABE H AND FUJISHIMA M. (1990). Risk of gastric cancer in patients with non-surgically treated peptic ulcer. Scand. J. Gastroenterol., 25, 1223-1226.
17. MIKI K, ICHINOSE M, SHIMIZU A, HUANG SC, OKA H, FURIHATA C, MATSHUSHIMA T AND TAKAHASHI K. (1987). Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterologica Japonica, 22, 133-141.
18. MIKI K, ICHINOSE M, ISHIKAWA KB, YAHAGI N, MATSUSHIMA M, KAKEI N, TSUKADA S, KIDO M, ISHIAMA S, SHIMIZU Y, SUZUKI T AND KUROKAWA K. (1993). Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Japan. J. Cancer Res., 84, 1086-1090.
19. PRICE AB. (1991). The Sydney system: histological division. J. Gastroenterol. Hepatol., 6, 209-222.
20. SAMLOFF IM. (1989). Peptic ulcer: the many proteases of aggression. Gastroenterology, 96, 586-595.
21. SAMLOFF IM, VARIS K, IHAMAKI T, SIURALA M AND ROTTER JI. (1982). Relationships among serum pepsinogen I, serum pepsinogen II and gastric mucosal histology. Gastroenterology, 83, 204-209.
22. SIPPONEN P. (1991). Long term consequences of gastroduodenal inflammation. Eur. J. Gastroenterol. Hepatol.,44, 525-529.
23. SIPPONEN P, KEKKI M, HAAPAKOSHI J, IHAMAKI T, SIURALA M. (1985). Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int. J. Cancer, 35, 173-177.
24. SITAS F, SMALLWOOD R, JEWELL D, MILLARD PR, NEWELL DG, MEUWISSEN SGM, MOSES S, ZWIES A AND FORMAN D. (1993). Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis. Cancer Epidemiol., Biomarkers and Prevention, 2, 119-123.
25. SORAHAN T, PARKES HG, VEYS C, WATERHOUSE JAH, STRANGHAN JK AND NUTT A. (1989). Mortality in the British rubber industry. Br. J. Ind. Med., 46, 1-11.
26. STEER HW, HAWTIN PR AND NEWELL DG. (1987). An Elisa technique for the serodiagnosis of Campylobacter pyloridis infection in patients with gastritis and benign duodenal ulceration. Serodiagnosis and Immunotherapy, 1, 253-259.
27. TALLEY NY, NEWELL DG, ORMOND JE, CARPENTER HE, WILSON WE, ZINSMEISTER AR, PEREZ-PEREZ GI AND BLASER MJ. (1991). Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J. Clin. Microbiol., 29, 1635-1639.
28. VARIS K. (1983). Surveillance of pernicious anaemia. In Precancerous Lesions of the Gastrointestinal Tract, Sherlock P, Morson BC, Barbara L and Veronese U (eds). pp. 189-194. Raven Press: New York.
29. VARIS K, SAMLOFF IM, IHAMAKI T AND SIURALA M. (1979). An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anaemia. Dig. Dis. Sci., 24, 187-191.
30. VARIS K, KEKKI M, HAKKINON M, SIPPONEN P AND SAMLOFF IM. (1991). Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand. J. Gastroenterol., 26, 117-123.
31. VEYS CA. (1985). Stomach cancer in Stoke-on-Trent is excessive: are the dusty trades implicated? Hum. Toxicol., 4, 100.
32. WEBB PM, KNIGHT TM, GREAVES S, WILSON A, NEWELL DG, ELDER JB AND FORMAN D. (1994). Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. Br. Med. J., 308, 750-753.
33. WESTERVELD BD, PALS G, LAMERS BHW, DEFIZE J, PRONK JC, FRANTS RR, OOMS CM, KREUNIG J, KOSTENSE PJ, ERIKSSON AW AND MEUWISSEN SGM. (1987). Clinical significance of pepsinogen A, isozymogens, serum pepsinogen A and C levels and serum gastrin levels. Cancer, 59, 952-958.
34. WYATT JI. (1995). Histopathology of gastroduodenal inflammation; the impact of Helicobacter pylori. Histopathology, 26, 1-15.